*Refresh the page if the below document does not appear.
Secretary General of IPA (Indian Pharmaceutical Alliance) on Thursday stated that the Indian pharma industry is expected to grow to $130 billion by 2030 and become the leading provider of medicines to the world.
AstraZeneca launched a new programme intending to upskill pharmacists in India. The program will contain content comprising inventory management, good pharmacy practices, customization of pharmacy for patients, and so on.
As per analysts, GSK will have to reduce the price of its antibiotics Ceftum and T- Bact that cumulatively contributes to 15% of its sales whereas Sanofi will have to reduce the price for Lantus which has a good share of 22% of its sales.
Out of 1330 drug samples, 1285 samples came out with standard quality in August’22. 45 drugs were found to be NSQ (Not of standard quality). However, none of the samples came out to be misbranded or spurious.
The Swiss competition commission (COMCO) started an investigation on Novartis over the alleged use of a patent illegally to decrease the competitive pressure.
Researchers at Cardiff University reviewed the earlier studies related to aspirin and Cancer and discovered the potential benefits of using aspirin that exceed side effects. The review was published in the journal ‘Open Biology’.
In the revised treatment guidelines, WHO
proposed against the use of Sotrovimab and
Casirivimab-Imdevimab for patients suffering
from Covid-19, stating that these might not be
effective against currently circulating variants
such as Omicron.
Please update your profile to keep using the website